v3.26.3
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Public Offering [Member]
Market Offering [Member]
Common Stock
Common Stock
Public Offering [Member]
Common Stock
Market Offering [Member]
Additional Paid-In Capital
Additional Paid-In Capital
Public Offering [Member]
Additional Paid-In Capital
Market Offering [Member]
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning Balance at Dec. 31, 2024 $ 629,838     $ 10     $ 1,579,750     $ 6 $ (949,928)
Beginning Balance, Shares at Dec. 31, 2024       102,318,629              
Issuance of stock, net of issuance costs     $ 140,653     $ 1     $ 140,652    
Issuance of stock, net of issuance costs, Shares           10,660,159          
Exercise of stock options 588           588        
Exercise of stock options, Shares       89,835              
Stock-based compensation 13,020           13,020        
Vesting of restricted stock units       565,159              
Unrealized gains (losses) on marketable securities 235                 235  
Net Income (Loss) (115,361)                   (115,361)
Ending Balance at Mar. 31, 2025 668,973     $ 11     1,734,010     241 (1,065,289)
Ending Balance, Shares at Mar. 31, 2025       113,633,782              
Beginning Balance at Dec. 31, 2024 629,838     $ 10     1,579,750     6 (949,928)
Beginning Balance, Shares at Dec. 31, 2024       102,318,629              
Unrealized gains (losses) on marketable securities 490                    
Net Income (Loss) (334,259)                    
Ending Balance at Sep. 30, 2025 691,783     $ 14     1,975,460     496 (1,284,187)
Ending Balance, Shares at Sep. 30, 2025       142,613,248              
Beginning Balance at Mar. 31, 2025 668,973     $ 11     1,734,010     241 (1,065,289)
Beginning Balance, Shares at Mar. 31, 2025       113,633,782              
Exercise of stock options 2,795           2,795        
Exercise of stock options, Shares       488,457              
Stock-based compensation 10,523           10,523        
Vesting of restricted stock units       216,371              
Unrealized gains (losses) on marketable securities 11                 11  
Net Income (Loss) (110,857)                   (110,857)
Ending Balance at Jun. 30, 2025 571,445     $ 11     1,747,328     252 (1,176,146)
Ending Balance, Shares at Jun. 30, 2025       114,338,610              
Issuance of stock, net of issuance costs   $ 215,803     $ 3     $ 215,800      
Issuance of stock, net of issuance costs, Shares         27,878,788            
Exercise of stock options 1,250           1,250        
Exercise of stock options, Shares       151,492              
Stock-based compensation 11,082           11,082        
Vesting of restricted stock units       244,358              
Unrealized gains (losses) on marketable securities 244                 244  
Net Income (Loss) (108,041)                   (108,041)
Ending Balance at Sep. 30, 2025 691,783     $ 14     1,975,460     496 (1,284,187)
Ending Balance, Shares at Sep. 30, 2025       142,613,248              
Beginning Balance at Dec. 31, 2025 972,129     $ 16     2,367,780     475 (1,396,142)
Beginning Balance, Shares at Dec. 31, 2025       164,950,540              
Exercise of stock options 1,311           1,311        
Exercise of stock options, Shares       88,932              
Stock-based compensation 13,081           13,081        
Vesting of restricted stock units       161,857              
Unrealized gains (losses) on marketable securities (612)                 (612)  
Net Income (Loss) (120,854)                   (120,854)
Ending Balance at Mar. 31, 2026 865,055     $ 16     2,382,172     (137) (1,516,996)
Ending Balance, Shares at Mar. 31, 2026       165,201,329              
Beginning Balance at Dec. 31, 2025 $ 972,129     $ 16     2,367,780     475 (1,396,142)
Beginning Balance, Shares at Dec. 31, 2025       164,950,540              
Exercise of stock options, Shares 425,148                    
Unrealized gains (losses) on marketable securities $ (1,478)                    
Net Income (Loss) (492,962)                    
Ending Balance at Sep. 30, 2026 930,933     $ 18     2,821,022     (1,003) (1,889,104)
Ending Balance, Shares at Sep. 30, 2026       187,328,238              
Beginning Balance at Mar. 31, 2026 865,055     $ 16     2,382,172     (137) (1,516,996)
Beginning Balance, Shares at Mar. 31, 2026       165,201,329              
Exercise of stock options 892           892        
Exercise of stock options, Shares       75,658              
Stock-based compensation 14,976           14,976        
Vesting of restricted stock units       393,893              
Unrealized gains (losses) on marketable securities (216)                 (216)  
Net Income (Loss) (178,556)                   (178,556)
Ending Balance at Jun. 30, 2026 702,151     $ 16     2,398,040     (353) (1,695,552)
Ending Balance, Shares at Jun. 30, 2026       165,670,880              
Issuance of stock, net of issuance costs   $ 404,907     $ 2     $ 404,905      
Issuance of stock, net of issuance costs, Shares         21,045,000            
Exercise of stock options 1,871           1,871        
Exercise of stock options, Shares       243,900              
Stock-based compensation 16,206           16,206        
Vesting of restricted stock units       368,458              
Unrealized gains (losses) on marketable securities (650)                 (650)  
Net Income (Loss) (193,552)                   (193,552)
Ending Balance at Sep. 30, 2026 $ 930,933     $ 18     $ 2,821,022     $ (1,003) $ (1,889,104)
Ending Balance, Shares at Sep. 30, 2026       187,328,238